Journal of Leukocyte Biology, 2022
Cytokine responses to LPS in reprogrammed monocytes are associated with the transcription factor PU.1

Tuerxun K., Midtbö K., Särndahl E. et al.

PLOS ONE, 2022
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease

Casselbrant A., Fedorowski A., Frantz S. et al.

Cells, 2022
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy

Wang H., Davison M., Kramer M. et al.

Cancers, 2022
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Gezelius E., Bendahl P., Gallo W. et al.

Diabetes, 2022
Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Ghanbari F., Yazdanpanah N., Yazdanpanah M. et al.

Life, 2022
Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart

Bhardwaj M., Schrotz-King P., Brenner H.

Journal of Internal Medicine, 2022
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

Arias de la Rosa I., López‐Montilla M., Román‐Rodríguez C. et al.

JACC: Basic to Translational Science, 2022
Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients

Kaye D., Nanayakkara S., Wang B. et al.

Atherosclerosis, 2022
Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort

Rastogi T., Girerd N., Lamiral Z. et al.

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementia

Vromen E., del Campo Milán M., Scheltens P. et al.

International Journal of Molecular Sciences, 2022
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19

Costanzo M., Caterino M., Fedele R. et al.

British Journal of Dermatology, 2022
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Navrazhina K., Frew J., Grand D. et al.

Brain, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity

Ruck T., Barman S., Schulte-Mecklenbeck A. et al.

Scientific Reports, 2022
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)

Klimczak-Tomaniak D., de Bakker M., Bouwens E. et al.

Life, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy

Johansson M., Ulfenborg B., Andersson C. et al.

Molecular Cancer, 2022
Proteomics technologies for cancer liquid biopsies

Ding Z., Wang N., Ji N. et al.

Journal of Thrombosis and Haemostasis, 2022
Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach

Rademaker E., Doorduijn D., Kusadasi N. et al.

PLOS ONE, 2022
Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study

Suhrs H., Nilsson M., Bové K. et al.

Journal of Viral Hepatitis, 2022
Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment

Khera T., Madsen L., Du Y. et al.

Digestive Diseases and Sciences, 2022
Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort

Shah S., Tarassishin L., Eisele C. et al.